Cargando…

Long-term Outcomes of Drug-eluting versus Bare-metal stent for ST-elevation Myocardial Infarction

BACKGROUND: Long-term outcomes of drug-eluting stents (DES) versus bare-metal stents (BMS) in patients with ST-segment elevation myocardial infarction (STEMI) remain uncertain. OBJECTIVE: To investigate long-term outcomes of drug-eluting stents (DES) versus bare-metal stents (BMS) in patients with S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Liping, Wang, Hongyun, Dong, Pingshuan, Li, Zhuanzhen, Wang, Yanyu, Duan, Nana, Zhao, Yuwei, Wang, Shaoxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079016/ https://www.ncbi.nlm.nih.gov/pubmed/25004414 http://dx.doi.org/10.5935/abc.20140070

Ejemplares similares

Furosemide with Saline Hydration for Prevention of Contrast-Induced Nephropathy in Patients undergoing Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials
por: Duan, Nana, et al.
Publicado: (2015)

Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction
por: Remkes, Wouter S, et al.
Publicado: (2016)

Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial
por: Schur, Nadine, et al.
Publicado: (2018)

Effectiveness of Drug-Eluting Stents versus Bare-Metal Stents in Large Coronary Arteries in Patients with Acute Myocardial Infarction
por: Sim, Doo Sun, et al.
Publicado: (2011)

Drug coated balloons and bare metal stents in ST-elevation myocardial infarction: eternal life or return of the living dead?
por: Farah, Ahmed, et al.
Publicado: (2023)

Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial
por: Sabaté, Manel, et al.
Publicado: (2016)

Everolimus- and sirolimus-eluting stents in patients with and without ST-segment elevation myocardial infarction
por: Velders, M. A., et al.
Publicado: (2014)

Severe thrombocytopenia soon after drug-eluting stent implantation in ST-elevation myocardial infarction
por: Łebek-Szatańska, Agnieszka, et al.
Publicado: (2015)

Are drug-eluting stents any better than bare metal? New evidence in non-ST-elevation acute coronary syndrome
por: Bahl, Rahul
Publicado: (2016)

Vascular response and intrastent thrombus in the early phase after drug‐eluting versus bare‐metal stent implantation in patients with ST‐segment elevation myocardial infarction: An observational, single‐center study
por: Sato, Nobuhiro, et al.
Publicado: (2018)

Comparison of drug-eluting and bare metal stents for extracranial vertebral artery stenting
por: Maciejewski, Damian R., et al.
Publicado: (2019)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents
por: Faramarzi, Negar, et al.
Publicado: (2013)

Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction
por: Desperak, Piotr, et al.
Publicado: (2020)

Identification of independent risk factors for restenosis following bare-metal stent implantation: Role of bare-metal stents in the era of drug-eluting stents
por: PARK, CHANG-BUM, et al.
Publicado: (2013)

Factors Associated with the Use of Drug-Eluting Stents in Patients Presenting with Acute ST-Segment Elevation Myocardial Infarction
por: Chavez, Jose F., et al.
Publicado: (2015)

Lesion Length Impacts Long Term Outcomes of Drug-Eluting Stents and Bare Metal Stents Differently
por: Chang, Shang-Hung, et al.
Publicado: (2013)

Very long-term efficacy and safety of paclitaxel-eluting balloon after a bare-metal stent for the treatment of ST-elevation myocardial infarction: 8-year results of a randomized clinical trial (PEBSI study)
por: García-Touchard, Arturo, et al.
Publicado: (2023)

Outcomes of stenting with overlapping drug-eluting stents versus overlapping drug-eluting and bare-metal stents for the treatment of diffuse coronary lesions
por: Kassaian, SE, et al.
Publicado: (2010)

Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography
por: Chen, B X, et al.
Publicado: (2008)

Drug-eluting versus bare-metal stents for first myocardial infarction in patients with atrial fibrillation: A nationwide population-based cohort study
por: Chang, Nen-Chung, et al.
Publicado: (2020)

ST-segment elevation versus non-ST-segment elevation myocardial infarction in current smokers after newer-generation drug-eluting stent implantation
por: Kim, Yong Hoon, et al.
Publicado: (2021)

Spectral Analysis Related to Bare-Metal and Drug-Eluting Coronary Stent Implantation
por: da Silva, Rose Mary Ferreira Lisboa, et al.
Publicado: (2014)

Comparison of the Efficacy of Drug-eluting Stents Versus Bare-metal Stents for the Treatment of Left Main Coronary Artery Disease
por: Wang, Xiao-Zeng, et al.
Publicado: (2015)

The Initial Extent of Malapposition in ST-Elevation Myocardial Infarction Treated with Drug-Eluting Stent: The Usefulness of Optical Coherence Tomography
por: Kim, Ung, et al.
Publicado: (2010)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
por: Yang, Yi-Xing, et al.
Publicado: (2020)

Comparison of bare metal stent and paclitaxel-eluting stent using a novel rat aorta stent model
por: Kwon, Jin Sook, et al.
Publicado: (2011)

Identification of functional modules induced by bare-metal stents and paclitaxel-eluting stents in coronary heart disease
por: Tang, Zhaobin, et al.
Publicado: (2018)

Vascular Responses to First-Generation Sirolimus-Eluting Stents and Bare-Metal Stents Beyond 10 Years
por: Hada, Masahiro, et al.
Publicado: (2021)

Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents
por: Ahmed, Talha, et al.
Publicado: (2022)

Exploring alternatives to drug-eluting stents: the potential of combining drug coated balloon with bare-metal stents
por: Murai, Kota, et al.
Publicado: (2023)

Efficacy of Drug-Eluting Stents in Diabetic Patients Admitted with ST-Elevation Myocardial Infarctions Treated with Primary Percutaneous Coronary Intervention
por: Schmucker, Johannes, et al.
Publicado: (2021)

Risk of Heart Failure in Patients with ST-Elevation Myocardial Infarction Receiving Drug-Eluting Stent Implantation and Undefined Duration of Antiplatelets
por: Chien, Li-Nien, et al.
Publicado: (2022)

Safety and Efficacy of Contemporary Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction and a High Ischemic Risk
por: Lee, Oh-Hyun, et al.
Publicado: (2022)

Nine-year clinical outcomes of drug-eluting stents vs. bare metal stents for large coronary vessel lesions
por: Yin, Dong, et al.
Publicado: (2017)

An unusual case of ST-segment elevation myocardial infarction following a late bare-metal stent fracture in a native coronary artery: a case report
por: Minardi, Giovanni, et al.
Publicado: (2009)

Long-term clinical outcomes of drug-eluting stents vs. bare-metal stents in Chinese geriatric patients
por: Chan, Pak-Hei, et al.
Publicado: (2013)

Stent implantation into the tracheo-bronchial system in rabbits: histopathologic sequelae in bare metal vs. drug-eluting stents
por: Sigler, Matthias, et al.
Publicado: (2015)

Efficacy and safety of sirolimus-eluting stents versus bare-metal stents in coronary artery disease patients with diabetes
por: Jing, Juehua
Publicado: (2014)

Cost-effectiveness of drug-eluting stents versus bare-metal stents in patients undergoing percutaneous coronary intervention
por: Baschet, Louise, et al.
Publicado: (2016)

Corrigendum: Safety and efficacy of contemporary drug-eluting stents in patients with ST-segment elevation myocardial infarction and a high ischemic risk
por: Lee, Oh-Hyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f2bkt1k3k0qnrs731hvlneg2qo